Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
This study is ongoing, but not recruiting participants.
Study NCT01495910   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received on November 23, 2011.   Last Updated on March 11, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
21-hydroxylase Deficiency
Additional conditions recognized in this trial
Adrenal Hyperplasia, Congenital
Adrenogenital Syndrome
More general conditions related to this trial
Adrenal Gland Diseases
Congenital Abnormalities
Disorders of Sex Development
Endocrine System Diseases
Genetic Diseases, Inborn
Gonadal Disorders
Metabolic Diseases
Metabolism, Inborn Errors
Steroid Metabolism, Inborn Errors
Urogenital Abnormalities
Interventions listed in this trial
Abiraterone acetate
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services